Completed Stereotactic Body Radiation Therapy, Tremelimumab and Durvalumab in Treating Participants With Recurrent or Metastatic Cervical, Vaginal, or Vulvar Cancers NCT03452332 Conditions Advanced Cervical Adenocarcinoma, Advanced Vaginal Carcinoma, Advanced Vulvar Carcinoma, +50 more Locations UT Southwestern/Simmons Cancer Center-Dallas — Dallas, Texas, United States M D Anderson Cancer Center — Houston, Texas, United States View Trial Details
